These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2852576)

  • 1. Hormone receptor assays: clinical usefulness in the management of carcinoma of the breast.
    Jordan VC; Wolf MF; Mirecki DM; Whitford DA; Welshons WV
    Crit Rev Clin Lab Sci; 1988; 26(2):97-152. PubMed ID: 2852576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical considerations of hormonal receptors in breast cancer.
    Skandalakis LJ; Winokur SH; Gray SW
    Am Surg; 1979 Sep; 45(9):556-60. PubMed ID: 228575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of immunochemical and radioligand binding assays for estrogen receptors in human breast tumors.
    Di Fronzo G; Miodini P; Brivio M; Cappelletti V; Coradini D; Granata G; Ronchi E
    Cancer Res; 1986 Aug; 46(8 Suppl):4278s-4281s. PubMed ID: 3524809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy for cancer of the breast. Current status of steroid hormone receptors.
    Osborne CK; McGuire WL
    West J Med; 1979 May; 130(5):401-7. PubMed ID: 516664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor status in breast cancer.
    Wright CJ
    Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated quantitation of immunocytochemically localized estrogen receptors in human breast cancer.
    McClelland RA; Finlay P; Walker KJ; Nicholson D; Robertson JF; Blamey RW; Nicholson RI
    Cancer Res; 1990 Jun; 50(12):3545-50. PubMed ID: 2187598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Are endocrine receptors determining factors for the prognosis of carcinoma of the breast?].
    De Lena M; Paradiso A; Maiello E
    Ric Clin Lab; 1985; 15 Suppl 2():63-71. PubMed ID: 3006215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlations of steroid receptors and male breast cancer.
    Everson RB; Lippman ME; Thompson EB; McGuire WL; Wittliff JL; De Sombre ER; Jensen EV; Singhakowinta A; Brooks SC; Neifeld JP
    Cancer Res; 1980 Apr; 40(4):991-7. PubMed ID: 7357565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of steroïd hormone receptors in the treatment of human breast cancer: a review.
    Osborne CK; McGuire WL
    Bull Cancer; 1979; 66(3):203-9. PubMed ID: 385079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptor assays: an Italian quality assessment program.
    Piffanelli A; Giovannini G; Pelizzola D; De Bortoli M; Catozzi L; Giganti M
    Ann Ist Super Sanita; 1991; 27(3):523-9. PubMed ID: 1809075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B; Geier A
    Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of dextran coated charcoal (DCC) and enzyme immunoassay (EIA) methods for oestrogen receptor (ER) estimation in breast cancer.
    Redkar AA; Kabre SS; Mittra I
    Indian J Cancer; 1991 Mar; 28(1):9-15. PubMed ID: 1769684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
    Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.